Basics Eton Pharmaceuticals, Inc. Common Stock IPO Date: November 13, 2018 Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic Market Cap: $384.56M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 2.77% Avg Daily Range (30 D): $0.44 | 3.32% Avg Daily Range (90 D): $0.48 | 3.41% Institutional Daily Volume Avg Daily Volume: .18M Avg Daily Volume (30 D): .22M Avg Daily Volume (90 D): .24M Trade Size Avg Trade Size (Sh.): 141 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 14 Avg Inst. Trade: $1.51M Avg Inst. Trade (30 D): $.81M Avg Inst. Trade (90 D): $.75M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.27M Avg Closing Trade (30 D): $.81M Avg Closing Trade (90 D): $.81M Avg Closing Volume: 471.97K         News May 9, 2024 @ 8:01 PM Eton Pharmaceuticals Reports First Quarter 2024 Fi... Source: Eton Pharmaceuticals May 1, 2024 @ 8:05 PM Eton Pharmaceuticals to Present at the Citizens JM... Source: Eton Pharmaceuticals Apr 30, 2024 @ 11:00 AM Eton Pharmaceuticals Announces Submission to FDA o... Source: Eton Pharmaceuticals Apr 29, 2024 @ 8:30 PM Eton Pharmaceuticals to Report First Quarter 2024 ... Source: Eton Pharmaceuticals Mar 22, 2024 @ 6:00 AM Eton Pharmaceuticals Announces Acquisition of PKU... Source: Eton Pharmaceuticals Financials   TTM Q4 2024 FY 2024 Basic EPS $-.15 $-.03 $-.15 Diluted EPS Revenue $ 39.01M $ 11.65M $ 39.01M Gross Profit $ 23.41M $ 6.48M $ 23.41M Net Income / Loss $ -3.82M $ -.6M $ -3.82M Operating Income / Loss $ -2.6M $ .63M $ -2.6M Cost of Revenue $ 15.6M $ 5.17M $ 15.6M Net Cash Flow $ -6.45M $ -5.33M $ -6.45M PE Ratio